FDA Approves Tauvid as First Tau Protein Tracer Tool for Alzheimer’s Diagnosis

Home / Alzheimer's / FDA Approves Tauvid as First Tau Protein Tracer Tool for Alzheimer’s Diagnosis
FDA Approves Tauvid as First Tau Protein Tracer Tool for Alzheimer’s Diagnosis
June 03, 2020June 3, 2020
0

The U.S. Food and Drug Administration (FDA) has approved Tauvid (flortaucipir F18) as an imaging radiotracer agent — a radioactive diagnostic tool — to efficiently detect clumps of tau protein in the brain, one of the hallmarks of Alzheimer’s disease. “Alzheimer’s disease is a devastating condition that affects millions of Americans. This approval will provide health care professionals with a new type of brain scan to use in patients being evaluated for Alzheimer’s disease,” Charles Ganley,…

You must be logged in to read/download the full post.

The post FDA Approves Tauvid as First Tau Protein Tracer Tool for Alzheimer’s Diagnosis appeared first on BioNewsFeeds.